The Anabolic Androgenic Steroid Research Group

Publications 2024

Abdullah R, Bjørnebekk A, Hauger LE, Hullstein IR, Edvardsen T, Haugaa KH, Almaas VM (2024)
Severe biventricular cardiomyopathy in both current and former long-term users of anabolic-androgenic steroids
Eur J Prev Cardiol, 31 (5), 599-608
DOI 10.1093/eurjpc/zwad362, PubMed 37992194

Almaas VM, Abdullah R, Edvardsen T, Haugaa KH, Bjørnebekk A (2024)
Comment on "Anabolic-androgenic steroids and cardiac function"
Eur J Prev Cardiol (in press)
DOI 10.1093/eurjpc/zwae183, PubMed 38788779

Finstad J, Røise O, Clausen T, Rosseland LA, Havnes IA (2024)
A qualitative longitudinal study of traumatic orthopaedic injury survivors' experiences with pain and the long-term recovery trajectory
BMJ Open, 14 (1), e079161
DOI 10.1136/bmjopen-2023-079161, PubMed 38191252

Gregersen I, Scarth ME, Abdullah R, Thorsby PM, Hauger LE, Haugaa KH, Sagen EL, Michelsen AE, Ueland T, Edvardsen T, Aukrust P, Almaas VM, Bjørnebekk AK, Halvorsen B (2024)
Elevated interleukin 8 and matrix metalloproteinase 9 levels are associated with myocardial pathology in users of Anabolic-Androgenic Steroids
Eur J Prev Cardiol (in press)
DOI 10.1093/eurjpc/zwae126, PubMed 38573232

Henriksen HCB, Havnes IA, Jørstad ML, Abdullah R, Thorsby PM, Hauger LE, Edvardsen T, Haugaa KH, Almaas VM, Bjørnebekk A (2024)
Treatment-seeking behavior and cardiovascular morbidity among men with anabolic-androgenic steroid use: A cross-sectional study
Scand J Med Sci Sports, 34 (1), e14554
DOI 10.1111/sms.14554, PubMed 38268076

Klonteig S, Scarth M, Bjørnebekk A (2024)
Sleep pathology and use of anabolic androgen steroids among male weightlifters in Norway
BMC Psychiatry, 24 (1), 62
DOI 10.1186/s12888-024-05516-6, PubMed 38254047

Publications 2023

Hauger LE, Lossius MI, Aaberg KM, Helmstaedter C, Lossius J, Skogan AH (2023)
Screening of attention and executive functions in pediatric patients at a tertiary epilepsy center
Eur J Paediatr Neurol, 46, 35-41
DOI 10.1016/j.ejpn.2023.06.006, PubMed 37418997

Henriksen HCB, Havnes IA, Jørstad ML, Bjørnebekk A (2023)
Health service engagement, side effects and concerns among men with anabolic-androgenic steroid use: a cross-sectional Norwegian study
Subst Abuse Treat Prev Policy, 18 (1), 19
DOI 10.1186/s13011-023-00528-z, PubMed 37013635

Jørstad ML, Scarth M, Torgersen S, Pope HG, Bjørnebekk A (2023)
Clustering psychopathology in male anabolic-androgenic steroid users and nonusing weightlifters
Brain Behav, 13 (7), e3040
DOI 10.1002/brb3.3040, PubMed 37150843

Scarth M, Hauger LE, Thorsby PM, Leknes S, Hullstein IR, Westlye LT, Bjørnebekk A (2023)
Supraphysiological testosterone levels from anabolic steroid use and reduced sensitivity to negative facial expressions in men
Psychopharmacology (Berl), 241 (4), 701-715
DOI 10.1007/s00213-023-06497-2, PubMed 37993638

Scarth M, Westlye LT, Havnes IA, Bjørnebekk A (2023)
Investigating anabolic-androgenic steroid dependence and muscle dysmorphia with network analysis among male weightlifters
BMC Psychiatry, 23 (1), 342
DOI 10.1186/s12888-023-04781-1, PubMed 37193971

Skauen JE, Pallesen S, Bjørnebekk A, Chegeni R, Syvertsen A, Petróczi A, Sagoe D (2023)
Prevalence and correlates of androgen dependence: a meta-analysis, meta-regression analysis and qualitative synthesis
Curr Opin Endocrinol Diabetes Obes, 30 (6), 309-323
DOI 10.1097/MED.0000000000000822, PubMed 37410490

Publications 2022

Bjørnebekk A, Scarth M, Neupane SP, Westlye LT, Hullstein IR, Thorsby PM, Halvorsen B (2022)
Use of High-Dose Androgens Is Associated with Reduced Brain-Derived Neurotrophic Factor in Male Weightlifters
Neuroendocrinology, 113 (1), 36-47
DOI 10.1159/000526418, PubMed 35944495

Bukten A, Lokdam NT, Skjærvø I, Ugelvik T, Skurtveit S, Gabrhelík R, Skardhamar T, Lund IO, Havnes IA, Rognli EB, Chang Z, Fazel S, Friestad C, Hesse M, Lothe J, Ploeg G, Dirkzwager AJE, Clausen T, Tjagvad C, Stavseth MR (2022)
PriSUD-Nordic-Diagnosing and Treating Substance Use Disorders in the Prison Population: Protocol for a Mixed Methods Study
JMIR Res Protoc, 11 (3), e35182
DOI 10.2196/35182, PubMed 35320114

Finstad J, Clausen T, Rosseland LA, Røise O, Havnes IA (2022)
Patient Experiences after Physical Trauma: The Negative Effect of the COVID-19 Pandemic on Recovery
Int J Environ Res Public Health, 19 (19)
DOI 10.3390/ijerph191912258, PubMed 36231553

Kildal E, Hassel B, Bjørnebekk A (2022)
ADHD symptoms and use of anabolic androgenic steroids among male weightlifters
Sci Rep, 12 (1), 9479
DOI 10.1038/s41598-022-12977-w, PubMed 35676515

Melsom HS, Heiestad CM, Eftestøl E, Torp MK, Gundersen K, Bjørnebekk AK, Thorsby PM, Stensløkken KO, Hisdal J (2022)
Reduced arterial elasticity after anabolic-androgenic steroid use in young adult males and mice
Sci Rep, 12 (1), 9707
DOI 10.1038/s41598-022-14065-5, PubMed 35690664

Scarth M, Havnes IA, Jørstad ML, McVeigh J, Van Hout MC, Westlye LT, Torgersen S, Bjørnebekk A (2022)
Severity of anabolic steroid dependence, executive function, and personality traits in substance use disorder patients in Norway
Drug Alcohol Depend, 231, 109275
DOI 10.1016/j.drugalcdep.2022.109275, PubMed 35030506

Scarth M, Jørstad ML, Reierstad A, Klonteig S, Torgersen S, Hullstein IR, Bjørnebekk A (2022)
Psychopathology among anabolic-androgenic steroid using and non-using female athletes in Norway
J Psychiatr Res, 155, 295-301
DOI 10.1016/j.jpsychires.2022.09.023, PubMed 36170757

Publications 2021

Bjørnebekk A, Kaufmann T, Hauger LE, Klonteig S, Hullstein IR, Westlye LT (2021)
Long-term Anabolic-Androgenic Steroid Use Is Associated With Deviant Brain Aging
Biol Psychiatry Cogn Neurosci Neuroimaging, 6 (5), 579-589
DOI 10.1016/j.bpsc.2021.01.001, PubMed 33811018

Finstad J, Røise O, Rosseland LA, Clausen T, Havnes IA (2021)
Discharge from the trauma centre: exposure to opioids, unmet information needs and lack of follow up-a qualitative study among physical trauma survivors
Scand J Trauma Resusc Emerg Med, 29 (1), 121
DOI 10.1186/s13049-021-00938-7, PubMed 34419130

Hauger LE, Havnes IA, Jørstad ML, Bjørnebekk A (2021)
Anabolic androgenic steroids, antisocial personality traits, aggression and violence
Drug Alcohol Depend, 221, 108604
DOI 10.1016/j.drugalcdep.2021.108604, PubMed 33621808

Havnes IA, Muller AE (2021)
Nonprescribed androgen use among women and trans men
Curr Opin Endocrinol Diabetes Obes, 28 (6), 595-603
DOI 10.1097/MED.0000000000000680, PubMed 34709214

Scarth M, Bjørnebekk A (2021)
Androgen abuse and the brain
Curr Opin Endocrinol Diabetes Obes, 28 (6), 604-614
DOI 10.1097/MED.0000000000000675, PubMed 34709215

Publications 2020

Bukten A, Lund IO, Kinner SA, Rognli EB, Havnes IA, Muller AE, Stavseth MR (2020)
Factors associated with drug use in prison - results from the Norwegian offender mental health and addiction (NorMA) study
Health Justice, 8 (1), 10
DOI 10.1186/s40352-020-00112-8, PubMed 32399643

Hauger LE, Westlye LT, Bjørnebekk A (2020)
Anabolic androgenic steroid dependence is associated with executive dysfunction
Drug Alcohol Depend, 208, 107874
DOI 10.1016/j.drugalcdep.2020.107874, PubMed 31972519

Havnes IA (2020)
DOPING Addiction, vanity and performance
Tidsskr. Nor. Laegeforen., 140 (5), 496

Havnes IA, Bukten A, Rognli EB, Muller AE (2020)
Use of anabolic-androgenic steroids and other substances prior to and during imprisonment - Results from the Norwegian Offender Mental Health and Addiction (NorMA) study
Drug Alcohol Depend, 217, 108255
DOI 10.1016/j.drugalcdep.2020.108255, PubMed 32949884

Havnes IA, Jørstad ML, Innerdal I, Bjørnebekk A (2020)
Anabolic-androgenic steroid use among women - A qualitative study on experiences of masculinizing, gonadal and sexual effects
Int J Drug Policy, 95, 102876
DOI 10.1016/j.drugpo.2020.102876, PubMed 32736958

Havnes IA, Jørstad ML, McVeigh J, Van Hout MC, Bjørnebekk A (2020)
The Anabolic Androgenic Steroid Treatment Gap: A National Study of Substance Use Disorder Treatment
Subst Abuse, 14, 1178221820904150
DOI 10.1177/1178221820904150, PubMed 32127749

Mutsaerts HJMM, Petr J, Groot P, Vandemaele P, Ingala S, Robertson AD, Václavů L, Groote I, Kuijf H, Zelaya F, O'Daly O, Hilal S, Wink AM, Kant I, Caan MWA, Morgan C, de Bresser J, Lysvik E, Schrantee A, Bjørnebekk A, Clement P, Shirzadi Z, Kuijer JPA, Wottschel V, Anazodo UC et al. (2020)
ExploreASL: An image processing pipeline for multi-center ASL perfusion MRI studies
Neuroimage, 219, 117031
DOI 10.1016/j.neuroimage.2020.117031, PubMed 32526385

Vaskinn A, Hauger LE, Bjørnebekk A (2020)
Theory of mind in users of anabolic androgenic steroids
Psychopharmacology (Berl), 237 (10), 3191-3199
DOI 10.1007/s00213-020-05603-y, PubMed 32623552

Publications 2019

Bjørnebekk A, Westlye LT, Walhovd KB, Jørstad ML, Sundseth ØØ, Fjell AM (2019)
Cognitive performance and structural brain correlates in long-term anabolic-androgenic steroid exposed and nonexposed weightlifters
Neuropsychology, 33 (4), 547-559
DOI 10.1037/neu0000537, PubMed 31033318

Hauger LE, Sagoe D, Vaskinn A, Arnevik EA, Leknes S, Jørstad ML, Bjørnebekk A (2019)
Anabolic androgenic steroid dependence is associated with impaired emotion recognition
Psychopharmacology (Berl), 236 (9), 2667-2676
DOI 10.1007/s00213-019-05239-7, PubMed 30941469

Hauger LE, Westlye LT, Fjell AM, Walhovd KB, Bjørnebekk A (2019)
Structural brain characteristics of anabolic-androgenic steroid dependence in men
Addiction, 114 (8), 1405-1415
DOI 10.1111/add.14629, PubMed 30955206

Havnes IA, Jørstad ML, Wisløff C (2019)
Anabolic-androgenic steroid users receiving health-related information; health problems, motivations to quit and treatment desires
Subst Abuse Treat Prev Policy, 14 (1), 20
DOI 10.1186/s13011-019-0206-5, PubMed 31096999

Pettersen H, Brodahl M, Rundgren J, Davidson L, Havnes IA (2019)
Partnering with persons in long-term recovery from substance use disorder: experiences from a collaborative research project
Harm Reduct J, 16 (1), 40
DOI 10.1186/s12954-019-0310-x, PubMed 31234878

Publications 2018

Haabrekke K, Siqveland T, Nygaaard E, Bjornebekk A, Slinning K, Wentzel-Larsen T, Walhovd KB, Smith L, Moe V (2018)
COGNITIVE AND SOCIOEMOTIONAL FUNCTIONING AT 4½ YEARS IN CHILDREN BORN TO MOTHERS WHO HAVE RECEIVED TREATMENT FOR SUBSTANCE-ABUSE PROBLEMS WHILE PREGNANT
Infant Ment Health J, 39 (5), 581-594
DOI 10.1002/imhj.21733, PubMed 30084491

Jørstad ML, Skogheim TS, Bergsund HB (2018)
[Not Available]
Nordisk Alkohol Nark, 35 (1), 69-76
DOI 10.1177/1455072517748871, PubMed 32934514

Muller AE, Havnes IA, Rognli EB, Bukten A (2018)
Inmates with Harmful Substance Use Increase Both Exercise and Nicotine Use Under Incarceration
Int J Environ Res Public Health, 15 (12)
DOI 10.3390/ijerph15122663, PubMed 30486386

Publications 2016

Bjørnebekk A, Walhovd KB, Jørstad ML, Due-Tønnessen P, Hullstein IR, Fjell AM (2016)
Structural Brain Imaging of Long-Term Anabolic-Androgenic Steroid Users and Nonusing Weightlifters
Biol Psychiatry, 82 (4), 294-302
DOI 10.1016/j.biopsych.2016.06.017, PubMed 27616036

Westlye LT, Kaufmann T, Alnæs D, Hullstein IR, Bjørnebekk A (2016)
Brain connectivity aberrations in anabolic-androgenic steroid users
Neuroimage Clin, 13, 62-69
DOI 10.1016/j.nicl.2016.11.014, PubMed 27942448

Publications 2015

Gaasland A, Havnes IA, Venberget M, Andresen JF (2015)
[Re: All suicides are not due to treatment failure]
Tidsskr Nor Laegeforen, 135 (18), 1625
DOI 10.4045/tidsskr.15.0964, PubMed 26442723

Gaasland A, Havnes IA, Venberget M, Andresen JF (2015)
All suicides are not due to treatment failure
Tidsskr. Nor. Laegeforen., 135 (18), 1625

Lie AK, Jensen T, Lichtwarck H, Storaas J, Torjussen E, Havnes IA (2015)
[Putting the patient at the center--already as a student]
Tidsskr Nor Laegeforen, 135 (14), 1236-7
DOI 10.4045/tidsskr.15.0702, PubMed 26269060

Sagoe D, McVeigh J, Bjørnebekk A, Essilfie MS, Andreassen CS, Pallesen S (2015)
Polypharmacy among anabolic-androgenic steroid users: a descriptive metasynthesis
Subst Abuse Treat Prev Policy, 10, 12
DOI 10.1186/s13011-015-0006-5, PubMed 25888931

 
Page visits: 2585